Interventions for tophi in gout-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interventions for tophi in gout

Published:2021-08-11 Issue:11 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sriranganathan Melonie K¹,Vinik Ophir²,Pardo Pardo Jordi³,Bombardier Claire⁴,Edwards Christopher J⁵

Affiliation:

1. Rheumatology Service, Department of General Medicine; Changi General Hospital; Singapore City Singapore

2. Division of Rheumatology; St Michael's Hospital; Toronto Canada

3. Ottawa Hospital Research Institute, The Ottawa Hospital - General Campus; Ottawa Canada

4. Toronto General Research Institute; University Health Network; Toronto Canada

5. Department of Rheumatology; University Hospital Southampton NHS Foundation Trust; Southampton UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference32 articles.

1. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study);Bardin;Annals of the Rheumatic Diseases,2017

2. Febuxostat compared with allopurinol in patients with hyperuricemia and gout;Becker;New England Journal of Medicine

3. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial;Arthritis & Rheumatology,2017

4. Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study;Dalbeth;Arthritis Research & Therapy,2019

5. Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study);Saag;Arthritis & Rheumatology,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110);Rheumatology and Therapy;2023-04-17

2. Are interventions for treatment of tophi in gout efficient? – A Cochrane Review summary with commentary;International Journal of Rheumatic Diseases;2023-03-09

3. Research Status of Susceptibility Genes of Primary Gout;Advances in Clinical Medicine;2023

4. Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia;Nature Communications;2022-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3